{"id":"W2921281835","doi":"10.1200/jco.2020.38.6_suppl.102","title":"KEYNOTE-365 cohort C updated results: Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Hospital; Western University","funders":"","keywords":"Medicine; Abiraterone; Enzalutamide; Cohort; Nausea; Prostate cancer; Cancer; Rash; Pembrolizumab; Internal medicine; Oncology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005158794,0.0008621078,0.0009824398,0.0004591757,0.0006181372,0.001347289,0.001284182,0.001161047,0.008034043],"category_scores_gemma":[0.004780246,0.0002889379,0.001489749,0.0008230539,0.000199096,0.0007183658,0.0006395049,0.001797793,0.001756656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002100087,"about_ca_system_score_gemma":0.003665319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01095209,"about_ca_topic_score_gemma":0.02286397,"domain_scores_codex":[0.9984729,0.0005356435,0.0001973179,0.000172331,0.0004333793,0.0001884701],"domain_scores_gemma":[0.9951434,0.0007039526,0.001436815,0.0003631934,0.001382603,0.0009700325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3231016,0.006608263,0.0579876,0.005937768,0.00583627,0.0006417262,0.0003417826,0.002643391,0.02410229,0.0005661647,0.3153087,0.2569244],"study_design_scores_gemma":[0.2225366,0.1105682,0.3757839,0.001951834,0.009330419,0.002011619,0.0002281007,0.001839922,0.01235671,0.0005799636,0.2625842,0.0002283852],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5054675,0.03047082,0.003758806,0.007550119,0.001991937,0.02050914,0.3715551,0.001015453,0.05768106],"genre_scores_gemma":[0.6580309,0.009232764,0.008207339,0.01098969,0.001554907,0.009722908,0.284319,0.0002481805,0.01769434],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01095209,"threshold_uncertainty_score":0.02728266,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1097738806320771,"score_gpt":0.4368679098113001,"score_spread":0.327094029179223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}